Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#141 / 200 Total
NXL - Nexalin Technology Inc - Stock Price Chart
TickerNXL [NASD]
CompanyNexalin Technology Inc
CountryUSA
IndustryMedical Devices
Market Cap10.12MEPS (ttm)-0.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y2.43%
P/S63.24EPS next 5Y-
P/B4.35EPS Q/Q-36.32%
Dividend-Sales Q/Q157.43%
Insider Own20.63%Inst Own0.70%
Insider Trans0.00%Inst Trans-
Short Float1.32%Earnings-
Analyst Recom-Target Price-
Avg Volume838.57K52W Range0.25 - 3.40
May-13-24 10:54AM NXL Stock Earnings: Nexalin Technology Reported Results for Q1 2024 (InvestorPlace)
May-09-24 08:30AM Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on May 23 (GlobeNewswire)
Apr-25-24 10:44AM Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements (GlobeNewswire)
Apr-10-24 08:30AM Nexalin Technology CEO Provides Letter to Shareholders (GlobeNewswire)
Apr-09-24 08:30AM Nexalin Technology Accelerates Manufacturing of its HALO Clarity Following Successful Usability, Feasibility, and Electrical Testing (GlobeNewswire)
Apr-04-24 01:00PM Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity , a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device (GlobeNewswire) -10.42%
11:05AM Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device (News Direct)
Apr-02-24 08:30AM Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board (GlobeNewswire) +51.05%
Mar-28-24 08:30AM Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego (GlobeNewswire) +79.49%
Mar-14-24 08:30AM Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's Technology (GlobeNewswire) +20.00%
CLVR - Clever Leaves Holdings Inc - Stock Price Chart
TickerCLVR [NASD]
CompanyClever Leaves Holdings Inc
CountryColombia
IndustryDrug Manufacturers - Specialty & Generic
Market Cap96.49MEPS (ttm)-4.71
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S5.54EPS next 5Y-
P/B0.15EPS Q/Q93.50%
Dividend-Sales Q/Q0.52%
Insider Own14.02%Inst Own0.25%
Insider Trans-0.04%Inst Trans-49.77%
Short Float0.09%EarningsApr 01/a
Analyst Recom3.00Target Price24.00
Avg Volume49.24K52W Range1.38 - 8.40
May-03-24 06:01AM Stock Market Crash Warning: Don't Get Caught Holding These 3 Cannabis Stocks (InvestorPlace)
Apr-29-24 07:33AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -60.58%
Apr-26-24 04:10PM Clever Leaves Announces Voluntary Delisting and SEC Deregistration (GlobeNewswire) +6.14%
Apr-01-24 08:54PM CLVR Stock Earnings: Clever Leaves Holdings Misses Revenue for Q4 2023 (InvestorPlace)
04:01PM Clever Leaves Reports Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Feb-13-24 08:30AM Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia (GlobeNewswire)
Jan-03-24 08:30AM Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA) (GlobeNewswire) +11.48%
Dec-16-23 01:31AM CLVR Shareholder News: Robbins LLP Reminds Investors it is Looking into the Officers and Directors of Clever Leaves Holdings Inc. (GlobeNewswire)
Dec-13-23 11:00AM Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses (GlobeNewswire) -6.90%
Dec-06-23 11:00AM Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses (GlobeNewswire) -5.49%
OLMA - Olema Pharmaceuticals Inc - Stock Price Chart
TickerOLMA [NASD, RUT]
CompanyOlema Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap550.91MEPS (ttm)-2.02
P/E-EPS this Y17.35%
Forward P/E-EPS next Y-46.18%
PEG-EPS past 5Y-105.28%
P/S-EPS next 5Y-
P/B2.33EPS Q/Q20.49%
Dividend-Sales Q/Q-
Insider Own13.09%Inst Own86.95%
Insider Trans7.06%Inst Trans-1.84%
Short Float17.29%EarningsMay 08/a
Analyst Recom1.10Target Price26.44
Avg Volume829.94K52W Range5.02 - 17.79
Today 07:01AM Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress (GlobeNewswire)
May-08-24 10:58PM OLMA Stock Earnings: Olema Pharmaceuticals Misses EPS for Q1 2024 (InvestorPlace)
04:02PM Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
07:02AM Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress (GlobeNewswire)
May-03-24 12:15PM Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 (PR Newswire) +5.96%
May-02-24 04:37PM Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-01-24 07:02AM Olema Oncology to Participate in Upcoming Investor Conferences in May (GlobeNewswire)
Apr-08-24 04:30PM Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference (GlobeNewswire) +5.33%
Apr-05-24 12:16AM Goldman Sachs Predicts Over 120% Rally for These 2 Strong Buy Stocks (TipRanks)
Apr-02-24 04:29PM Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
GDRX - GoodRx Holdings Inc - Stock Price Chart
TickerGDRX [NASD]
CompanyGoodRx Holdings Inc
CountryUSA
IndustryHealth Information Services
Market Cap2.73BEPS (ttm)-0.02
P/E-EPS this Y29.63%
Forward P/E16.38EPS next Y22.26%
PEG-EPS past 5Y-
P/S3.57EPS next 5Y26.30%
P/B4.32EPS Q/Q67.50%
Dividend-Sales Q/Q7.55%
Insider Own79.32%Inst Own14.63%
Insider Trans0.06%Inst Trans-5.59%
Short Float10.95%EarningsMay 09/b
Analyst Recom2.19Target Price8.76
Avg Volume1.42M52W Range4.14 - 9.37
Today 12:01PM Update: GoodRx Signs Direct Contracting Agreement With Kroger; GoodRx Shares Rise (MT Newswires) +9.32%
09:12AM Sector Update: Health Care Stocks Rise Pre-Bell Wednesday (MT Newswires)
06:48AM GoodRx Signs Direct Contracting Agreement With Kroger (MT Newswires)
06:00AM GoodRx and Kroger Sign Direct Contracting Agreement (Business Wire)
May-14-24 02:25PM Investors in GoodRx Holdings, Inc. Should Contact Levi & Korsinsky Before June 21, 2024 to Discuss Your Rights GDRX (GlobeNewswire)
May-13-24 07:27AM Deutsche Bank Adjusts GoodRx Price Target to $8 From $9, Maintains Hold Rating (MT Newswires)
May-10-24 03:16PM GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:10PM GoodRx Holdings Inc (GDRX) Q1 2024 Earnings: Navigates Market Challenges with Strategic Adjustments (GuruFocus.com)
May-09-24 10:30PM GoodRx (GDRX) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) -8.94%
06:15PM GoodRx (GDRX) Q1 2024 Earnings Call Transcript (Motley Fool)
ABEO - Abeona Therapeutics Inc - Stock Price Chart
TickerABEO [NASD]
CompanyAbeona Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap186.70MEPS (ttm)-2.59
P/E-EPS this Y25.43%
Forward P/E-EPS next Y17.14%
PEG-EPS past 5Y38.92%
P/S53.34EPS next 5Y-
P/B-EPS Q/Q-114.59%
Dividend-Sales Q/Q-
Insider Own5.40%Inst Own48.58%
Insider Trans2.13%Inst Trans15.03%
Short Float8.92%EarningsMay 15/b
Analyst Recom1.00Target Price19.50
Avg Volume693.93K52W Range2.83 - 9.01
Today 12:53PM ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q1 2024 (InvestorPlace) +12.14%
07:43AM Abeona Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress (GlobeNewswire)
May-07-24 07:30AM Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-03-24 11:19AM Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise (MT Newswires) +13.02%
07:30AM Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Apr-23-24 02:04PM Top Midday Decliners (MT Newswires) -53.67%
08:53AM Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today? (InvestorPlace)
07:39AM Top Premarket Decliners (MT Newswires)
07:09AM FDA rejects Abeona cell therapy, asks for more manufacturing data (BioPharma Dive)
HKD - AMTD Digital Inc ADR - Stock Price Chart
TickerHKD [NYSE]
CompanyAMTD Digital Inc ADR
CountryFrance
IndustrySoftware - Application
Market Cap103.00MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y107.64%
P/S3.70EPS next 5Y-
P/B1.58EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own0.28%
Insider Trans-Inst Trans-87.23%
Short Float5.46%Earnings-
Analyst Recom-Target Price-
Avg Volume495.93K52W Range2.92 - 8.42
May-14-24 07:34AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) +12.95%
Apr-30-24 04:10PM AMTD Group Inc. Announces the Adoption of a Completely Independent and Non-Executive Board Structure and an Innovative CEO Rotation System Across the Group (Business Wire)
04:10PM AMTD Digital Recorded Solid Half Yearly Performance (Business Wire)
04:10PM AMTD Digital Announces Change of Fiscal Year End (Business Wire)
Feb-14-24 09:23AM AMTD Digital Announces a New Share Repurchase Program (Business Wire)
Feb-09-24 09:31AM AMTD World Media And Entertainment Group Embraces Full Independent Board Structure, Ready For Its 2.0 Stage Of Development And Growth In The Global Domain (Business Wire)
Feb-05-24 08:59AM AMTD Digital Successfully Completed Its Share Repurchase Program (Business Wire)
Jan-26-24 09:26AM AMTD Digitals Entertainment and Movie Businesses Are Estimated to Contribute Significantly to Net Profit (Business Wire)
Jan-25-24 09:18AM AMTD Digitals Half Yearly Net Profit is Estimated to Increase over 150% Year over Year (Business Wire)
Dec-29-23 09:13AM AMTD Movie Goldfinger will be Globally Released tomorrow across U.S., Canada, U.K., Australia, New Zealand, and major cities across Asia (Business Wire)
VINO - Gaucho Group Holdings Inc - Stock Price Chart
TickerVINO [NASD]
CompanyGaucho Group Holdings Inc
CountryUSA
IndustryReal Estate - Diversified
Market Cap3.50MEPS (ttm)-5.71
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y12.64%
P/S1.63EPS next 5Y-
P/B3.69EPS Q/Q50.42%
Dividend-Sales Q/Q42.07%
Insider Own14.58%Inst Own8.94%
Insider Trans0.00%Inst Trans-
Short Float1.22%Earnings-
Analyst Recom1.00Target Price13752.00
Avg Volume91.72K52W Range3.89 - 84.00
Today 10:45AM Gaucho Holdings Achieves Key Nasdaq Milestone (ACCESSWIRE) -6.62%
May-14-24 11:45AM Gaucho Holdings Announces Record Growth in Argentine Wine Market (ACCESSWIRE)
May-07-24 11:15AM Gaucho Group Holdings, Inc. Supports Strong Investment in Argentina Following Endorsements from Global Leaders (ACCESSWIRE) +18.35%
May-06-24 09:15AM Gaucho Group Holdings, Inc. Observes Notable Surge In Buenos Aires Real Estate Market (ACCESSWIRE) -5.67%
May-01-24 09:15AM Gaucho Group Holdings Announces Completion of Reverse Stock Split (ACCESSWIRE) -20.02%
Apr-29-24 09:00AM Gaucho Group Holdings, Inc. Announces Reverse Stock Split (ACCESSWIRE)
Apr-24-24 08:30AM Gaucho Group Holdings Receives Notice from Nasdaq Regarding Continued Listing Requirements (ACCESSWIRE)
Apr-19-24 10:00AM Gaucho Group Holdings Responds to Positive Economic Shifts in Argentina (ACCESSWIRE)
Apr-16-24 08:00PM Gaucho Group Holdings Announces Delay in Annual Report Filing (ACCESSWIRE)
Apr-09-24 08:30AM Gaucho Group Holdings Announces Strategic Measures to Streamline Operations and Cost Efficiencies (ACCESSWIRE) +14.61%
ERNA - Eterna Therapeutics Inc - Stock Price Chart
TickerERNA [NASD]
CompanyEterna Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap11.47MEPS (ttm)-4.25
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y0.06%
P/S95.58EPS next 5Y20.00%
P/B-EPS Q/Q-16.30%
Dividend-Sales Q/Q-
Insider Own48.42%Inst Own7.38%
Insider Trans0.00%Inst Trans-23.43%
Short Float1.23%Earnings-
Analyst Recom1.00Target Price60.00
Avg Volume9.05K52W Range0.84 - 2.99
May-14-24 10:53PM ERNA Stock Earnings: Eterna Therapeutics Reported Results for Q1 2024 (InvestorPlace) +9.81%
May-10-24 08:00AM Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases (GlobeNewswire) -6.48%
May-08-24 09:31AM Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board (GlobeNewswire) +12.12%
May-07-24 08:00AM Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on the Development of a mRNA-Engineered iPSC Line which Mimics Native B2M Expression, via Targeted Insertion of HLA-E at the B2M Locus (GlobeNewswire) +12.50%
08:00AM Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases (GlobeNewswire)
Mar-15-24 08:53AM ERNA Stock Earnings: Eterna Therapeutics Reported Results for Q4 2023 (InvestorPlace)
Feb-20-24 08:30AM Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors (GlobeNewswire)
Jan-03-24 04:15PM Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4) (GlobeNewswire)
Dec-21-23 11:18AM Eterna Therapeutics Appoints Sanjeev Luther as President and CEO (Exec Edge)
Dec-20-23 04:15PM Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer (GlobeNewswire) +9.87%
FENC - Fennec Pharmaceuticals Inc - Stock Price Chart
TickerFENC [NASD, RUT]
CompanyFennec Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap189.16MEPS (ttm)0.04
P/E188.65EPS this Y185.28%
Forward P/E12.17EPS next Y12.05%
PEG-EPS past 5Y-2.95%
P/S4.21EPS next 5Y-
P/B62.77EPS Q/Q281.18%
Dividend-Sales Q/Q1413.24%
Insider Own14.60%Inst Own58.65%
Insider Trans-7.72%Inst Trans0.73%
Short Float7.84%EarningsMay 14/b
Analyst Recom1.17Target Price15.87
Avg Volume147.21K52W Range6.30 - 11.92
Today 08:44AM HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating (MT Newswires)
May-14-24 10:53AM FENC Stock Earnings: Fennec Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) -26.75%
07:20AM Fennec Pharmaceuticals Swings to Q1 Profit on Higher Sales, Licensing Revenue (MT Newswires)
06:03AM Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-07-24 06:15PM Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024 (GlobeNewswire)
Apr-23-24 08:01AM Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing (MT Newswires)
Apr-05-24 07:00PM Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC) (GuruFocus.com)
Mar-27-24 07:00PM Chief Financial Officer Robert Andrade Sells 13,975 Shares of Fennec Pharmaceuticals Inc (FENC) (GuruFocus.com)
Mar-26-24 01:00AM Chief Financial Officer Robert Andrade Sells Shares of Fennec Pharmaceuticals Inc (FENC) (GuruFocus.com)
Mar-22-24 09:49AM Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript (Insider Monkey)
FOSL - Fossil Group Inc - Stock Price Chart
TickerFOSL [NASD, RUT]
CompanyFossil Group Inc
CountryUSA
IndustryLuxury Goods
Market Cap59.81MEPS (ttm)-2.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-111.68%
P/S0.04EPS next 5Y14.90%
P/B0.26EPS Q/Q41.85%
Dividend-Sales Q/Q-21.58%
Insider Own10.80%Inst Own58.50%
Insider Trans0.00%Inst Trans-7.99%
Short Float12.88%EarningsMay 08/a
Analyst Recom4.00Target Price3.75
Avg Volume783.70K52W Range0.75 - 2.92
Today 06:04AM Why the 2024 meme stock action is much tamer than 2021 so far (Yahoo Finance) -7.38%
May-10-24 09:51AM Fossil Group, Inc. (NASDAQ:FOSL) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 06:56AM Q1 2024 Fossil Group Inc Earnings Call (Thomson Reuters StreetEvents)
03:53AM Fossil Group Inc (FOSL) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-08-24 10:55PM FOSL Stock Earnings: Fossil Group Reported Results for Q1 2024 (InvestorPlace)
06:30PM Fossil Group Sees First-Quarter Revenues Slide After a Dismal 2023 (WWD)
06:06PM Fossil Group: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM Fossil Group, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 01:09PM Fossil Group (FOSL) Fell Due to Near-Term Revenue Headwinds (Insider Monkey) +12.68%
12:56PM Gray Television (GTN) Was Under Pressure in Q1 (Insider Monkey)
1⋯1011121314151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.